Fibrodysplasia Ossificans Progressiva (FOP) Recruiting Phase 2 Trials for Saracatinib (DB11805)

Also known as: FOP / Fibrodysplasia Ossificans Progressiva / Myositis ossificans progressiva, unspecified site / Myositis ossificans progressiva / Progressive myositis ossificans / Progressive myositis ossificans (disorder)

IndicationStatusPhase
DBCOND0086420 (Fibrodysplasia Ossificans Progressiva (FOP))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04307953Saracatinib Trial TO Prevent FOPTreatment